STOCK TITAN
  1. Home
  2. Sec-filings
  3. ECOR
  4. [DEF 14A] electroCore, Inc. Definitive Proxy Statement

[DEF 14A] electroCore, Inc. Definitive Proxy Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
DEF 14A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ECOR logo
Electrocore

NASDAQ:ECOR

ECOR Rankings

#7829 Ranked by Market Cap
N/A Ranked by Dividends

ECOR Latest News

Aug 12, 2025
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
Aug 6, 2025
electroCore Announces Second Quarter 2025 Financial Results
Aug 5, 2025
electroCore Appoints James C. Theofilos to the Board of Directors
Jul 23, 2025
electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025
Jul 22, 2025
electroCore to Participate in Upcoming Investor Conferences

ECOR Latest SEC Filings

Aug 12, 2025
[Form 4] electroCore, Inc. Insider Trading Activity
Aug 6, 2025
[10-Q] electroCore, Inc. Quarterly Earnings Report
Aug 5, 2025
[Form 4] electroCore, Inc. Insider Trading Activity
Aug 5, 2025
[Form 3] electroCore, Inc. Initial Statement of Beneficial Ownership
Jul 18, 2025
[S-3/A] electroCore, Inc. Amended Shelf Registration Statement

ECOR Stock Data

51.74M
5.19M
30.2%
18.57%
5.43%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY